Matches in SemOpenAlex for { <https://semopenalex.org/work/W2757546831> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2757546831 endingPage "E271" @default.
- W2757546831 startingPage "E271" @default.
- W2757546831 abstract "To evaluate the risk of second malignancies after seed migration in prostate cancer patients treated with I-125 free seeds brachytherapy. Data from 2067 prostate cancer patients treated with I-125 free seeds brachytherapy in three Canadian centers were analyzed. Kaplan-Meier method was used to estimate the 5- and 7-year biochemical relapse-free and overall survival between patients who experienced or not seed migration. Mean age and Median follow-up was 64 years and 44 (range 1-147) months, respectively. Seed migration occurred in 365 of 2067 patients (17.7%). The 5-, 7-year biochemical relapse-free and overall survival for the entire cohort was 96%, 91.7% and 95.9%, 93.7%, respectively. Second malignancies occurred in 4 of 365 patients (1.1%) and 21 of 1702 patients (1.2%) in patients with or without seed migration, respectively (p=0.827). Lung cancer represented the most frequent second malignancy observed and occurred in 6 patients, all in the no seed migration group. The other second malignancies observed in the no seed migration group included: larynx (3 patients), colon (2 patients), esophagus (2), pancreatic (2), renal, myeloma, glioblastoma, non-Hodgkin’s lymphoma (1) and 2 unknown. In the seed migration group, the second malignancies observed were chronic myeloid leukemia (1), colo-rectal cancer (2) and nasopharynx (1). These short-term results do not support an increased risk of second malignancies, particularly lung cancer with seed migration after I-125 free seeds brachytherapy for prostate cancer patients. Due to the low rate of second malignancies observed in this cohort, further studies with longer follow-up are required to better correlate seed migration and second malignancies." @default.
- W2757546831 created "2017-10-06" @default.
- W2757546831 creator A5010341407 @default.
- W2757546831 creator A5015716448 @default.
- W2757546831 creator A5022553681 @default.
- W2757546831 creator A5028108855 @default.
- W2757546831 creator A5029150206 @default.
- W2757546831 creator A5031603264 @default.
- W2757546831 creator A5037727718 @default.
- W2757546831 creator A5046424007 @default.
- W2757546831 creator A5049072127 @default.
- W2757546831 creator A5062370609 @default.
- W2757546831 creator A5064363717 @default.
- W2757546831 creator A5072160450 @default.
- W2757546831 creator A5080231515 @default.
- W2757546831 date "2017-10-01" @default.
- W2757546831 modified "2023-10-09" @default.
- W2757546831 title "The Risk of Second Malignancies after Seed Migration in Prostate Cancer Patients Treated With I-125 Free Seeds Brachytherapy" @default.
- W2757546831 doi "https://doi.org/10.1016/j.ijrobp.2017.06.1250" @default.
- W2757546831 hasPublicationYear "2017" @default.
- W2757546831 type Work @default.
- W2757546831 sameAs 2757546831 @default.
- W2757546831 citedByCount "0" @default.
- W2757546831 crossrefType "journal-article" @default.
- W2757546831 hasAuthorship W2757546831A5010341407 @default.
- W2757546831 hasAuthorship W2757546831A5015716448 @default.
- W2757546831 hasAuthorship W2757546831A5022553681 @default.
- W2757546831 hasAuthorship W2757546831A5028108855 @default.
- W2757546831 hasAuthorship W2757546831A5029150206 @default.
- W2757546831 hasAuthorship W2757546831A5031603264 @default.
- W2757546831 hasAuthorship W2757546831A5037727718 @default.
- W2757546831 hasAuthorship W2757546831A5046424007 @default.
- W2757546831 hasAuthorship W2757546831A5049072127 @default.
- W2757546831 hasAuthorship W2757546831A5062370609 @default.
- W2757546831 hasAuthorship W2757546831A5064363717 @default.
- W2757546831 hasAuthorship W2757546831A5072160450 @default.
- W2757546831 hasAuthorship W2757546831A5080231515 @default.
- W2757546831 hasBestOaLocation W27575468311 @default.
- W2757546831 hasConcept C121608353 @default.
- W2757546831 hasConcept C126322002 @default.
- W2757546831 hasConcept C143998085 @default.
- W2757546831 hasConcept C2776235491 @default.
- W2757546831 hasConcept C2777416452 @default.
- W2757546831 hasConcept C2779399171 @default.
- W2757546831 hasConcept C2779742542 @default.
- W2757546831 hasConcept C2780192828 @default.
- W2757546831 hasConcept C509974204 @default.
- W2757546831 hasConcept C71924100 @default.
- W2757546831 hasConcept C90924648 @default.
- W2757546831 hasConceptScore W2757546831C121608353 @default.
- W2757546831 hasConceptScore W2757546831C126322002 @default.
- W2757546831 hasConceptScore W2757546831C143998085 @default.
- W2757546831 hasConceptScore W2757546831C2776235491 @default.
- W2757546831 hasConceptScore W2757546831C2777416452 @default.
- W2757546831 hasConceptScore W2757546831C2779399171 @default.
- W2757546831 hasConceptScore W2757546831C2779742542 @default.
- W2757546831 hasConceptScore W2757546831C2780192828 @default.
- W2757546831 hasConceptScore W2757546831C509974204 @default.
- W2757546831 hasConceptScore W2757546831C71924100 @default.
- W2757546831 hasConceptScore W2757546831C90924648 @default.
- W2757546831 hasIssue "2" @default.
- W2757546831 hasLocation W27575468311 @default.
- W2757546831 hasOpenAccess W2757546831 @default.
- W2757546831 hasPrimaryLocation W27575468311 @default.
- W2757546831 hasRelatedWork W2010020620 @default.
- W2757546831 hasRelatedWork W2027294118 @default.
- W2757546831 hasRelatedWork W2062703397 @default.
- W2757546831 hasRelatedWork W2138863125 @default.
- W2757546831 hasRelatedWork W2165532162 @default.
- W2757546831 hasRelatedWork W2165919621 @default.
- W2757546831 hasRelatedWork W2378574446 @default.
- W2757546831 hasRelatedWork W2979210130 @default.
- W2757546831 hasRelatedWork W4200366280 @default.
- W2757546831 hasRelatedWork W4243514755 @default.
- W2757546831 hasVolume "99" @default.
- W2757546831 isParatext "false" @default.
- W2757546831 isRetracted "false" @default.
- W2757546831 magId "2757546831" @default.
- W2757546831 workType "article" @default.